Hints and tips:
Related Special Reports
...Initial high efficacy rates of the shots excited some investors and boosted hopes that mRNA would be successful in other big vaccine markets, from improving the efficacy of flu vaccines to tackling tough...
...A person familiar with the process said Merck “understood there was no hope . . . [Lagevrio] is a bit burnt”....
...The drugmakers Pfizer and Roche said they are piloting use of rFC at some of their facilities....
...Pfizer’s expertise in mRNA — the core technology used in the Covid vaccine — also provides opportunities, he added. But in the short term, Pfizer is reliant on its existing pipeline....
...Merck’s drug raised fresh hopes and sent shares in the company rallying late last year after early data from a late-stage trial suggested that it cut in half the risk of death and hospitalisation....
...The rest of the country, in particular under-equipped rural areas, have even dimmer hopes of acquiring the drug given the low import volumes....
...Peter Marks, head of the unit that authorises vaccines at the FDA, said: “The hope here is that by increasing the amount of antibodies we have to that particular variant, we will restore the kind of protection...
...Despite initial hopes, both drugmakers struggled to establish themselves on the Covid-19 vaccines market, now largely dominated by BioNTech/Pfizer and Moderna, which enjoyed significant first-mover advantage...
.... ©2023 Nikkei Inc. All rights reserved....
...“Initially there was hope that it would be, not a miracle drug, but it would be the solution to Covid,” he said. “But I don’t think it is going to turn out to be.”...
...“These top-line safety, immunogenicity and efficacy data are encouraging, and we look forward to soon completing our submissions to regulators globally with the hope of making this vaccine available to younger...
...The French and British pharmaceutical companies hope the shot will help them catch up after they fell far behind in the race to supply Covid vaccines....
...US government advisers have recommended the approval of a fourth Covid-19 jab developed by Novavax, expressing hopes that it can help boost the nation’s flagging immunisation programme as a new wave of infections...
...Pfizer and BioNTech hope that a shot based on mRNA technology will be easier to scale up than Shingrix, which is a protein-based vaccine with an adjuvant....
...Pfizer and BioNTech started enrolling participants in a trial of their mRNA flu shot last September....
...“There’s no reason to believe that this medicine isn’t equally effective against Omicron, and for that reason could be our best hope, and biggest beneficiary, of the coming global Omicron wave,” Porges added...
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The trial results boosted hopes that the developed world will soon have access to enough vaccines and drugs to bring an end to a 19-month pandemic that has battered the global economy and claimed more than...
...The Moderna vaccine increased the levels of antibodies the most, followed by the BioNTech/Pfizer shot, and even a half-dose of the Pfizer shot performed well....
...My two mixed-breed dogs, Pfizer and AstraZeneca, adopted during the pandemic, climb on my knees, asking to be stroked....
...Investors also hope the antiviral could speed the recovery of the whole economy....
...A version of this article was first published by Nikkei Asia on July 19. ©2022 Nikkei Inc. All rights reserved....
...Vaccine makers have been pushing back against a proposal to waive intellectual property rights on Covid jabs — put forward by South Africa and India and backed by the US — in the hope of expanding access...
...That is a measure of the hopes pinned on mRNA pioneers in the face of the latest threat. A big advantage of this technology is its adaptability....
...Last week the drugmaker unveiled an ambitious array of drug development programmes using mRNA technology, which it hopes to deploy to treat diseases ranging from cancer to heart disease....
International Edition